United States · Platforms & data · The Motley Fool

Wave Life Sciences (WVE) Q3 2026 Earnings Call Transcript

Published by The Motley Fool · United States 2 h ago

RNA medicine company advances obesity and lung disease programs with $431M cash runway.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Greenbrier Companies, Inc. (The) (NYSE:GBX) Stock Has Average Price Target of $42.67

Is that used EV worth the price? This checklist could save you thousands of dollars.

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Galaxy Digital Stock Surges After Quarterly Earnings Crush Estimates

Novartis Raises Guidance After Trial Setbacks Hit Profit

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge